[Effect of sevoflurane on the neuromuscular blockade produced by continuous mivacurium infusion ]

J Barrio1, I Asensio, I Molina

  • 1Servicio de Anestesiología y Reanimación, Hospital Arnau de Vilanova, Valencia. jabama16@hotmail.com

Abstract

Insights

Sevoflurane significantly intensifies neuromuscular blockade when administered with mivacurium infusions. This potentiation effect persists for at least 15 minutes after sevoflurane is no longer present in the blood.

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Neuromuscular blockade

Background:

  • Mivacurium is a short-acting neuromuscular blocking agent used in anesthesia.
  • Sevoflurane is a common volatile anesthetic agent.
  • Understanding drug interactions is crucial for patient safety during surgery.

Purpose of the Study:

  • To investigate the impact of sevoflurane on mivacurium-induced neuromuscular blockade.
  • To quantify the changes in neuromuscular function during and after sevoflurane administration.

Main Methods:

  • Fourteen patients undergoing orthopedic surgery received anesthesia with propofol and remifentanil.
  • Neuromuscular blockade was monitored using acceleromyography of the adductor pollicis muscle.
  • Mivacurium was administered via continuous infusion to maintain a stable submaximal block (T1 between 40-60%).

Main Results:

  • Sevoflurane administration led to a significant decrease in the train-of-four ratio (T4/T1) and the first response (T1).
  • Neuromuscular blockade was significantly deeper during sevoflurane administration compared to baseline.
  • The enhanced neuromuscular blockade persisted for at least 15 minutes after sevoflurane discontinuation.

Conclusions:

  • Sevoflurane significantly potentiates the neuromuscular blocking effects of mivacurium.
  • The potentiation effect is sustained even after the elimination of sevoflurane from the body.
  • Clinical implications include the need for careful titration of neuromuscular blocking agents when used concurrently with sevoflurane.

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...